logo

Spectrum Pharmaceuticals Inc (SPPI)



Trade SPPI now with
  Date
  Headline
6/29/2018 7:08:55 AM Spectrum Pharma Presents ADVANCE Phase 3 ROLONTIS (eflapegrastim) Data At MASCC 2018
5/3/2018 7:23:46 AM Spectrum Pharma Announces Licensing Agreement On Certain Methods Of Use Of Poziotinib
5/1/2018 7:07:50 AM Spectrum Enters Next-Generation Sequencing Companion Diagnostic Partnership With Thermo Fisher Scientific
4/10/2018 5:02:32 AM Spectrum Pharma Says Update Of MD Anderson’s Phase 2 Data Studying Poziotinib In EGFR Exon 20 Mutant NSCLC Patients
3/6/2018 4:02:12 PM Spectrum Pharma Q4 Loss/share $0.29 Vs. Loss $0.23 Year Ago
2/27/2018 6:06:17 AM Spectrum Pharma Names William Ashton To Its Board
2/5/2018 7:06:44 AM Spectrum Pharma: ROLONTIS (eflapegrastim) Met Primary Endpoint In Phase 3 ADVANCE Study
12/18/2017 11:59:34 AM B. Riley Initiates Spectrum Pharmaceuticals Inc (SPPI) At Buy With $26 Price Target
12/13/2017 7:04:01 AM Spectrum Pharma Highlights Two Oral Presentations On FOLOTYN At ASH
10/30/2017 7:10:29 AM Spectrum Begins Multicenter Phase 2 Trial Of Poziotinib In NSCLC Patients With Exon 20 Insertion Mutation In EGFR